Understanding Biology’s Blueprint: 8 Questions with Kat Hadjantonakis
Learn about Anna-Katerina “Kat” Hadjantonakis, who is Chair of the Sloan Kettering Institute’s Developmental Biology Program.
Related Articles
Breast Cancer and Weight Gain: How To Control It During and After
Learn how to control weight gain during and after breast cancer treatment, from experts at MSK.
FDA Approves New Drug Combination for ER+, HER2- Breast Cancer
Learn how a three-drug treatment appears to be very effective for ER+, HER2- breast cancers.
FDA Approves New Drug Combination for ER+, HER2- Breast Cancer
Learn how a three-drug treatment appears to be very effective for ER+, HER2- breast cancers.
Power and Precision: Proton Therapy Can Target Brain and Spine Tumors
Learn how MSK doctors are using proton therapy to treat tumors of the brain and spinal cord.
Gerstner Sloan Kettering Graduate Students Receive 2024-2025
Nine GSK PhD students were awarded competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).
MSK Awards and Appointments September 2024
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:
Phase II Trial of Proton Re-Irradiation+/-Chemotherapy in Previously Irradiated Recurrent Head/Neck Cancer
To report the results of a multi-center phase II trial of using proton re-irradiation (re-RT) for previously irradiated recurrent head/neck cancer (HNC).
Top doctors talk what to know about breast cancer
A panel of top doctors in the field answers questions from a group of breast cancer survivors, thrivers and caregivers.
The Olayan Center for Cancer Vaccines at MSK
Pioneering science and transformative clinical trials to accelerate precision vaccines as the next breakthrough cancer therapy.
Resolution Revolution: How a New Microscope Is Offering MSK Scientists
How cryo-electron microscopy is providing scientists at MSK with an unprecedented view of the wild and wiggly microcosm inside our cells.